Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative tranexamic acid versus placebo for blood loss reduction in high-risk postpartum haemorrhage women undergoing caesarean section
PACTR202510738673777Not yet recruiting
- Sponsor
- Self
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial in postpartum hemorrhage (PPH) comparing Tranexamic acid with Placebo (2 arms). Primary endpoint: Mean blood loss during surgery and up to 24 hours after surgery. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
tranexamic acid
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on PACTR202510738673777.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202510738673777.